Grace Wright, MD PhD FACR

Dr Wright is a consultant rheumatologist in New York City. She earned her medical and doctorate degrees at the NYU School of Medicine, completed her internship, residency and chief residency in internal medicine and a fellowship in rheumatology at the NYU Medical Center and served as Clinical Associate Professor of Medicine.
In 2014, Dr. Wright founded the Association of Women in Rheumatology (AWIR) which has since grown to over 50 local chapters throughout the United States as well as a growing number of international members in more than 120 countries. She is a member of multiple global rheumatology organizations (ACR, EULAR, BSR, SBR, CRA and GRAPPA) and currently serves as the co-chair of the OMERACT EQUITY Group.
Dr Wright has been recognized as a Woman in Motion by the Arthritis Foundation, and as a “Rheumatology Hero” by the American College of Rheumatology. In 2022 she received the American College of Physicians Recognition of “Women in Medicine” award and was also recognized by the Global Health and Living Foundation as a “Beacon for Better Health”.
Dr. Wright has designed and participated in clinical research, has been published in multiple peer-reviewed journals, and lectures extensively at national and international conferences on rheumatic diseases, with a special focus on Rheumatology, Immunology, Signaling pathways, and the impact of Equity on Rheumatology Healthcare providers and patients.
Financial relationships
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AbbvieTopic:Rheumatic diseasesDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AstraZenecaTopic:Lupus, rheumatologyDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Bristol Myers SquibbTopic:RA, Psoriatic disease, Cell therapyDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Eli LillyTopic:Psoriatic disease, Spondyloarthritis, ObesityDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Fate TherapeuticsTopic:CAR-TDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Johnson & JohnsonTopic:Psoriatic disease, Health EquityDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:NovartisTopic:Spondyloarthritis, Psoriatic disease, Health equityDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:PfizerDate added:05/04/2026Date updated:05/04/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:UCBTopic:Rheumatic diseasesDate added:05/04/2026Date updated:05/04/2026

Facebook
X
LinkedIn
Forward